Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 25.8B | 25.5B | 27.2B | 27.3B |
Cost of revenue | 6.5B | 7.2B | 8.5B | 8.7B |
Gross profit | 19.4B | 18.3B | 18.7B | 18.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.8B | 1.8B | 1.8B | 1.7B |
Other operating expenses | 8.9B | 8.4B | 9.3B | 8.6B |
Operating income | 5.1B | 4.8B | 4.3B | 5.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 941.7M | 894.8M | 911.0M | 883.7M |
Other income expense | 8.3B | -98.9M | -299.1M | -2.6M |
Pretax income | 12.5B | 3.8B | 3.0B | 4.1B |
Tax provision | 3.1B | 1.0B | -945.9M | 1.1B |
Net income | 9.4B | 2.8B | 4.0B | 3.0B |
Basic EPS | — | 0.9 | 1.3 | 0.9 |
Diluted EPS | — | 0.9 | 1.2 | 0.9 |
Basic average shares | — | 3.2B | 3.2B | 3.3B |
Diluted average shares | — | 3.2B | 3.3B | 3.3B |
EBITDA | 16.8B | 8.0B | 7.4B | 8.3B |
Net income from continuing op. | 9.4B | 2.8B | 4.0B | 3.0B |
Minority interests | 67.3M | 67.3M | 79.3M | 45.2M |
Preferred stock dividends | — | — | — | — |